We describe the cautionary case of a patient with advanced-stage large B-cell lymphoma (DLBCL). After combination chemotherapy, CT-PET revealed a persistent focus of likely DLBCL for which he received radiotherapy. Follow-up CT-PET showed diffuse hypermetabolic adenopathy and recurrent DLBCL was presumed. As part of clinical trial assessment, multiple biopsies showed non-caseating lymphadenitis consistent with sarcoidosis. No treatment for asymptomatic sarcoidosis was required and 18 months later he remains cancer-free. The presentation of sarcoidosis masquerading as recurrent DLBCL highlights the importance of tissue sampling prior to engaging in toxic and potentially life-threatening chemotherapy and the interesting link between DLBCL and...
Herein, we aimed to report a diffuse large B cell lymphoma (DLBCL) case that had extensive cutaneous...
Abstract: We present a case of a 45-year-old woman with primary Sjögren's syndrome, who in 2005...
Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgk...
Introduction There is a reported association between sarcoidosis and malignancy. This is particularl...
Sarcoidosis is a systemic, chronic inflammatory disease with unknown cause and is characterized by f...
Abstract: Sarcoidosis is a granulomatous disease that most frequently affects the lungs with pulmona...
AbstractSarcoidosis is an inflammatory, systemic disease characterized by noncaseating granulomas. W...
Case Report: Diffuse Large B Cell Lymphoma (DLBCL) is an aggressive tumor of B cells that can arise ...
We report a patient with sarcoidosis who developed diffuse large B-cell lymphoma. A 71-year-old woma...
Sarcoidosis is a multisystem granulomatous disease commonly involving the lungs and mediastinal lymp...
We report a 52-year-old patient who developed B-cell non-Hodgkin's lymphoma subsequent to sarcoidosi...
Sarcoidosis is a multisystem inflammatory disease characterized by non-caseating granulomas which ma...
The association between sarcoidosis and lymphoproliferative diseases is well-recognized. As fluorine...
Copyright © 2015 Mazen Zaarour et al.This is an open access article distributed under the Creative C...
Standard endocrine therapy and chemotherapy can induce long-term remission in breast cancer patients...
Herein, we aimed to report a diffuse large B cell lymphoma (DLBCL) case that had extensive cutaneous...
Abstract: We present a case of a 45-year-old woman with primary Sjögren's syndrome, who in 2005...
Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgk...
Introduction There is a reported association between sarcoidosis and malignancy. This is particularl...
Sarcoidosis is a systemic, chronic inflammatory disease with unknown cause and is characterized by f...
Abstract: Sarcoidosis is a granulomatous disease that most frequently affects the lungs with pulmona...
AbstractSarcoidosis is an inflammatory, systemic disease characterized by noncaseating granulomas. W...
Case Report: Diffuse Large B Cell Lymphoma (DLBCL) is an aggressive tumor of B cells that can arise ...
We report a patient with sarcoidosis who developed diffuse large B-cell lymphoma. A 71-year-old woma...
Sarcoidosis is a multisystem granulomatous disease commonly involving the lungs and mediastinal lymp...
We report a 52-year-old patient who developed B-cell non-Hodgkin's lymphoma subsequent to sarcoidosi...
Sarcoidosis is a multisystem inflammatory disease characterized by non-caseating granulomas which ma...
The association between sarcoidosis and lymphoproliferative diseases is well-recognized. As fluorine...
Copyright © 2015 Mazen Zaarour et al.This is an open access article distributed under the Creative C...
Standard endocrine therapy and chemotherapy can induce long-term remission in breast cancer patients...
Herein, we aimed to report a diffuse large B cell lymphoma (DLBCL) case that had extensive cutaneous...
Abstract: We present a case of a 45-year-old woman with primary Sjögren's syndrome, who in 2005...
Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgk...